Founder, Incisive Ventures · angel in 2 deals
Every published round Martin Tobias took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Factory | Series A | 27 Jan 2026 | $4.7m | Participant | Startup Daily (Fri 30 Jan 2026), SmartCompany, Startup Daily (Wed 28 Jan 2026), Shearwater Capital, Beachhead Venture Capital portfolio, Shearwater Capital portfolio | |
| Series A - 2025 | Series A | Jan 2026 | $4.7m | Participant | thesaasnews.com, Beachhead Venture Capital portfolio, Shearwater Capital portfolio |
Companies Martin Tobias has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Factory | 27 Jan 2026, Series A | 1 | 0 | |
| Series A - 2025 | Job shop software for fabricators to quote, schedule, and invoice | Jan 2026, Series A | 1 | 0 |
Fund closes reported for Martin Tobias, as distinct from the investments it has made.
Companies Martin Tobias has backed that another company then bought. An exit for the holding, not a deal Martin Tobias did.
Stories naming Martin Tobias. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Sydney maker of manufacturing software Factory has closed a 4.69 million Australian dollar Series A led by Shearwater Capital, with several co-investors, to build product, grow sales and enter the United States.
Roundup of six Australian funding deals: AutoGrab, Applied EV, Checkbox, Hometime, Factory and On the House, with amounts, investors, and Hometime's past acquisitions and raise history detailed.
Also Startup Daily
Sydney manufacturing software startup Factory has raised a $4.69 million Series A led by Shearwater Capital to build product capacity and expand into the US, after a seed round from Investible in 2023.
Wholesale Investor promotes an investment offering in Bioself, maker of the Sensate relaxation device, which is raising USD1 million through a SAFE and has previously drawn backing from several named investors.
UK and US medtech firm Bioself Technology, maker of the Sensate relaxation device, is raising USD$1 million via a SAFE with over 40 percent already committed, backed by two US venture firms and an angel.